Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Intra-Cellular Therapies Inc | 0 | 147,750 | +147,750 | $0 | $12.34M | 10.58% | +$12.34M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 321,898 | 173,144 | -148,754 | $10.59M | $9.59M | 8.22% | -$1.00M |
| Insmed Incorporated(INSM) | 150,833 | 114,360 | -36,473 | $11.01M | $7.90M | 6.77% | -$3.12M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 66,661 | +66,661 | $0 | $5.64M | 4.84% | +$5.64M |
| Xenon Pharmaceuticals Inc.(XENE) | 211,791 | 129,291 | -82,500 | $8.34M | $5.07M | 4.35% | -$3.27M |
| CG Oncology, Inc.(CGON) | 263,266 | 174,048 | -89,218 | $9.93M | $4.99M | 4.28% | -$4.94M |
| Merus N V | 208,244 | 116,796 | -91,448 | $10.40M | $4.91M | 4.21% | -$5.49M |
| Blueprint Medicines Corp | 106,080 | 55,892 | -50,188 | $9.81M | $4.87M | 4.18% | -$4.94M |
| Janux Therapeutics, Inc.(JANX) | 108,811 | 90,292 | -18,519 | $4.94M | $4.83M | 4.14% | -$109.0K |
| Centessa Pharmaceuticals PlcADS | 309,614 | 244,538 | -65,076 | $4.95M | $4.10M | 3.51% | -$854.7K |
| Soleno Therapeutics Inc | 0 | 87,629 | +87,629 | $0 | $3.94M | 3.38% | +$3.94M |
| Geron Corporation(GERN) | 1,331,053 | 1,074,824 | -256,229 | $6.04M | $3.80M | 3.26% | -$2.24M |
| Alumis Inc | 418,416 | 445,259 | +26,843 | $4.47M | $3.50M | 3.00% | -$968.9K |
| Praxis Precision Medicines, Inc.(PRAX) | 73,185 | 44,982 | -28,203 | $4.21M | $3.46M | 2.97% | -$749.3K |
| Trevi Therapeutics, Inc.(TRVI) | 1,322,800 | 781,489 | -541,311 | $4.42M | $3.22M | 2.76% | -$1.20M |
| Enliven Therapeutics Inc | 234,856 | 141,710 | -93,146 | $6.00M | $3.19M | 2.73% | -$2.81M |
| Korro Bio, Inc.(KRRO) | 0 | 70,678 | +70,678 | $0 | $2.69M | 2.31% | +$2.69M |
| Jasper Therapeutics, Inc.(JSPR) | 399,466 | 122,424 | -277,042 | $7.51M | $2.62M | 2.24% | -$4.90M |
| EyePoint, Inc.(EYPT) | 0 | 348,000 | +348,000 | $0 | $2.59M | 2.22% | +$2.59M |
| Whitehawk Therapeutics, Inc.(WHWK) | 0 | 817,939 | +817,939 | $0 | $2.58M | 2.21% | +$2.58M |
| Atyr Pharma Inc | 0 | 699,730 | +699,730 | $0 | $2.53M | 2.17% | +$2.53M |
| 89bio Inc | 0 | 317,833 | +317,833 | $0 | $2.49M | 2.13% | +$2.49M |
| Tyra Biosciences, Inc.(TYRA) | 270,075 | 175,063 | -95,012 | $6.35M | $2.43M | 2.09% | -$3.92M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 106,434 | +106,434 | $0 | $2.32M | 1.99% | +$2.32M |
| Mind Medicine Mindmed Inc | 788,508 | 330,275 | -458,233 | $4.49M | $2.30M | 1.97% | -$2.19M |
| Edgewise Therapeutics, Inc.(EWTX) | 187,695 | 83,176 | -104,519 | $5.01M | $2.22M | 1.90% | -$2.79M |
| Springworks Therapeutics Inc | 227,700 | 54,692 | -173,008 | $7.30M | $1.98M | 1.69% | -$5.32M |
| Context Therapeutics Inc.(CNTX) | 1,757,524 | 1,576,762 | -180,762 | $3.44M | $1.66M | 1.42% | -$1.79M |
| Promis Neurosciences Inc | 1,592,605 | 1,592,605 | 0 | $1.99M | $1.51M | 1.29% | -$481.3K |
| Climb Bio, Inc.(CLYM) | 1,229,292 | 760,225 | -469,067 | $6.26M | $1.37M | 1.17% | -$4.89M |
| Applied Therapeutics Inc | 618,332 | 0 | -618,332 | $5.26M | $0 | — | -$5.26M |
| Disc Medicine, Inc.(IRON) | 100,000 | 0 | -100,000 | $4.91M | $0 | — | -$4.91M |
| Kura Oncology, Inc.(KURA) | 294,081 | 0 | -294,081 | $5.75M | $0 | — | -$5.75M |
| Longboard Pharmaceuticals In | 240,892 | 0 | -240,892 | $8.03M | $0 | — | -$8.03M |
| Perspective Therapeutics, Inc.(CATX) | 341,739 | 0 | -341,739 | $4.56M | $0 | — | -$4.56M |
| Relay Therapeutics, Inc.(RLAY) | 626,058 | 0 | -626,058 | $4.43M | $0 | — | -$4.43M |
| Revolution Medicines, Inc.(RVMD) | 163,500 | 0 | -163,500 | $7.41M | $0 | — | -$7.41M |
| Sarepta Therapeutics, Inc.(SRPT) | 72,000 | 0 | -72,000 | $8.99M | $0 | — | -$8.99M |